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SUMMARY. The reproducibility of albumin concentration in firstmorning samples of urine was assessed in 334 insulin-dependent diabetic patients aged 18-60 years.
The albumin excretion rate was determined immunoturbidimetrically in three sterile, Albustix-negative, first-morning urine samples submitted over a week. An abnormally high mean value, 3 2 * 5 mg albumin per mmol creatinine (Ua/Uc), was found in 33 patients (9.9%). These patients were older (mean 42 vs 34 years. P<O-Ol), had longer disease duration (18 vs 14 years, P<O.Ol) and higher HbA,c values (6-8 vs 6.39'0, P < 0.05) than those without microalbuminuria. Although triplicate samples were collected within 7 days, Ua/Uc showed considerable intraindividual variation, with a mean coefficient of variation of 49%. Despite this it was found that Ua/Uc values greater than 1 rng/mmol on the first specimen had a sensitivity of 97% and a specificity of 82% for detecting those with a three-sample mean value greater than 2.5 mg/mmol. Thus virtually all those with microalbuminuria (32/33) had a single first-rnorning result greater than 1 mg/rnmol, and in those with a lower ratio microalbuminuria was excluded with more than 99% certainty.
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Microalbuminuria is said to be present when urinary albumin excretion is above normal yet below that detected by a standard dipstick test (e.g. Albustix, Ames, Slough, UK). It has been defined as an albumin excretion rate (AER) of 20-200 pg/min, equating approximately to 30-300 mg/24h.l-6 Its presence is highly predictive of the development of overt diabetic nephropathy, a complication which affects up to 40% of individuals with long-standing diabetes.'
It has been suggested that the progression from microalburninuria to macroalbuminuria in diabetes may be slowed by the implementation of antihypertensive medication,*-'l strict metabolic control,12-14 and dietary protein restriction. ls Easy identification of patients with microalbuminuria is therefore important. The substantial intraindividual variation in albumin excretion, however, makes detection of microalbuminuria difficult.' Problems in obtaining accurately timed urine collections have led to the use of untimed samples by many investigators who suggest that these are adequate for identifying patients with microalbuminuria by making the assumption that urinary albumin concentration reflects AER. 16-m The first-morning sample of urine (FMU), in particular, is said to correlate well with timed overnight or 24h AER.16*'7g19-25-29 Furthermore, albumin concentration can be expressed as a function of creatinine excretion (albumin/creatinine ratio, Ua/Uc), which reduces variability due to changing rates of water excretion.16~18-20~22~z3~26 Thus it appears that the result of first-morning samples of urine expressed as Ua/Uc is the most suitable simple screening test for microalbuminuria in diabetic population^.^^.^^ Few studies have investigated the short-term variation in albumin excretion in FMU in large numbers of diabetic patients.
The present study was carried out to examine the reproducibility of albumin excretion in FMUs and to assess the validity of reliance on a single FMU in identifying insulin-dependent diabetic patients with rnicroalbuminuria. The prevalence of microalbuminuria and its associated clinical features were also defined in the study population.
PATIENTS AND METHODS
Three hundred and ninety-five Type 1 (insulindependent) diabetic patients aged between 18 and 60 years were invited to participate in the study while attending for routine out-patient review at the regional diabetic clinic. The presence of proteinuria on routine dipstick testing (Albustix) or of known urine infection excluded participation. Blood pressure was recorded using a standard mercury sphygmomanometer under routine clinic conditions and a venous blood sample taken. A midstream specimen of urine was sent for microscopy and culture. Each patient was asked to post three fresh FMUs directly to the laboratory within the following week.
Urinary albumin was measured by an immunoturbidimetric methodZo on a random access fully automated analyser. The incubation was performed in a buffer of high ionic strength to overcome the variable pH and buffering capacity of different wines. An anti-human antibody produced by the Scottish Antibody Production Unit (Carluke, UK) was used. The interassay coefficient of variation of the method was 5% at 20mg/L. Serum urine and creatinine were measured using an adaptation of the Jaffk method.31 Plasma glucose was measured on capillary samples by a glucose oxidase on a Beckman Glucose Analyzer 2 (Beckman Instruments, Brea, CA, USA) and HbAlc by high performance liquid chromatography (KDK Daiichi, Kyoto, Japan; non-diabetic reference range 4.0-5.3%). Plasma glucose was estimated with minimal delay on samples collected while the patient attended the clinic. Serum creatinine and HbA,c were measured the same day on venous samples while urinary albumin and creatinine were measured on samples posted the previous morning by the patient.
Urinary albumin excretion was expressed as mg albumin per mmol of creatinine (Ua/Uc) for each sample. Raw data were used to calculate the CV for individual urinary albumin excretion rates. The non-normally distributed individual mean values were log transformed before statistical analysis by Student's t test and Pearson correlation using a computer package (Minitab Inc, State College, PA, USA).
RESULTS
Of the 395 patients invited to participate in the study, 353 (89%) returned all three urine samples.
Twelve patients who were found to have a positive urine culture and seven who sent in Albustixpositive samples were not included in the analysis. Fig. 1 . A mean Ua/Uc of greater than 2 -5 mg/mmol, which is a sensitive indicator of AER > 30 gg/min26.33g34 and therefore considered a positive result, was found in 33 patients (9-9Vo).
The clinical and biochemical characteristics of patients with and without microalbuminuria are compared in Table 1 . The patients with microalbuminuria were older, had longer disease duration and higher mean HbAlc level. There were no significant differences in age at diagnosis, body mass index, systolic or diastolic blood pressure, or serum creatinine. The mean log Ua/Uc showed a significant correlation only with HbAlc ( r = 0 -1 9 3 , P<O.OOl) and diabetes duration (r=O-125, P<O-O5).
Despite the short time period over which samples were collected there was great intraindividual variation in albumin concentration in the three first-morning samples (mean CV 60%, range 1-164%). This variability was reduced somewhat by correcting for creatinine excretion which gave a three-sample mean CV for Ua/Uc of 49% (range 1-161%).
The ability of the initial FMU submitted to predict a three-sample mean Ua/Uc value greater than 2 . 5 mg/mmol, that is, positive for microalbuminuria, is shown in Fig. 2 . The results are As seen in previous studies where repeat measurements were made over a longer time ~c a l e~~~~~~~~~~~~~-~~ it would appear that there is substantial natural variation in AER which cannot be readily accounted for by methodological considerations, and which is just as great when repeat samples are collected over days as over a longer time period.
Despite the high degree of variability, the possibility of using a single FMU to detect those with microalbuminuria was investigated. This approach would have obvious practical advantages for preliminary screening in an outpatient clinic setting. The sensitivity and specificity of the result of the first sample, at various discriminating values, in identifying patients with a three-sample mean Ua/Uc 8 2 . 5 mg/mmol was calculated and it was found that a cut-off value as low as 1 mg/mmol was necessary to produce the high sensitivity (97%) required of a screening test. The negative predictive value of this cut-off level was such that one could exclude microalbuminuria with almost 100% certainty in the 248 patients having a Ua/Uc of less than 1 mg/mmol on a first sample. The penalty in terms of less satisfactory specificity of this cut-off value (82%) would have amounted to 54 'false positives' on the 334 initial samples. These patients together with the 32 'true positives' would have amounted to 26% of the initial patient population requiring further measurements to establish microalbuminuric status, perhaps at subsequent routine clinic visits.
In evaluating the above screening method for microalbuminuria it is worth comparing the anticipated performance of the semi-quantitative side room tests which have been d e s~r i b e d .~~.~~-~l The tests currently being promoted are designed to give a positive result at urinary albumin concentrations above 20-30 mg/L. Applying the lower figure to the initial urinary albumin concentrations in the current study, it was found that while 90% of 'positive' samples (i.e. > 20 mg/L) had a three-sample mean Ua/Uc 8 2 . 5 mg/mmol, the sensitivity of 55% was unacceptably low as 15 of 33 microalbuminuric patients had an initial urinary albumin concentration below 20mg/L. This would suggest that currently available concentration-dependent methods for detecting microalbuminuria on spot urine samples are unreliable for screening.
In conclusion, the use of first-morning urine samples is proposed for preliminary screening of diabetic patient for microalbuminuria with a cutoff value as low as 1 mg/mmol being used to discriminate between 'positive' and 'negative' results. Using a three-sample mean Ua/Uc 3 2 . 5 mg/mmol as a reference standard, a single sample cut-off value of 1 mg/mmol gave a high sensitivity (97%) and reasonable specificity (82%), and could be recommended as a level below which no further action is required and above which further investigation of albumin excretion should be initiated. 
